Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer

计划入组 28 人 · 首次发布于 2019 年 7 月 23 日

A Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Fruquintinib in the Treatment of Immunodominant pMMR/MSS Metastatic Colorectal Cancer That Has Failed Second-line or Above Treatment

计划入组 18 人 · 首次发布于 2025 年 11 月 17 日

QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer

计划入组 50 人 · 首次发布于 2020 年 8 月 26 日

Colorectal cancer (MSS) (BreakBio)

Oncolipin-IT Colorectal Cancer

Deflexifol

Austrian Breast & Colorectal Cancer Study Group

Austria

BORDEAUX COLORECTAL INSTITUTE ACADEMY

France

Cardiff Oncology

United States

ViroMissile's IDOV-Safe Shows 30-46% Response Rate in Treatment-Resistant Colorectal Cancer

Combination Therapies Show Promise in Treating MSS Metastatic Colorectal Cancer

Anbogen and BeiGene Collaborate to Evaluate Combination Therapy in Colorectal Cancer